Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Stroke | Commentary

Liberal versus conservative oxygen therapy in critically ill patients: using the fragility index to determine robust results

Authors: Maria Vargas, Giuseppe Servillo

Published in: Critical Care | Issue 1/2019

Login to get access

Excerpt

Guidelines on the use of supplemental oxygen for various acute illnesses in adults are contradictory and inconsistent, and at this time no high-quality evidence base exists [1]. Although many randomized controlled trials (RCTs) comparing liberal versus conservative oxygen for various critical conditions have been done, the trial data are not conclusive [2]. With this in mind, we read with great interest the just published systematic review and meta-analysis by Chu et al. [2] on mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy. The authors stated that liberal supplemental oxygen was harmful and associated with a dose-dependent increased risk of short-term and long-term mortality [2]. Chu et al. performed an excellent statistical analysis and a robust trial sequential analysis. Our major concern is about the fragility of the included trials. As we know from the current literature, RCTs are designed to assess objectively the safety and efficacy of a specific intervention [3]. Recently the fragility index (FI), an intuitive measure of the robustness of RCTs, was introduced in the critical care area [4]. Studies with larger FI values have more robust findings compared with the studies with poor FI values [3, 4]. We evaluated the FI of the RCTs included in the meta-analysis by Chu et al. using a two-by-two contingency table and p value produced by Fisher exact test [4]. Surprisingly, we found that 18 RCTs had a FI of 0 while the unpublished data from trial NCT00414726 had a FI of 2 (Table 1). Furthermore, we looked at the statistical significance of the mortality reported in the included study and found that only the study by Girardis et al. [5] reached statistical significance in the primary outcome.
Table 1
Fragility index calculated for the study included in the systematic review and meta-analysis by Chu et al. [1]
Study
Setting
Liberal group (FiO2 0.52 CI:0.39-0.85)
Conservative group (FiO2 0.21 CI:0.21-0.50)
p value for mortality in each study
Fragility index n (p)
Ali et al. (2014) [6]
Stroke
5/155
4/146
0.99
0 (1)
Roffe et al. (2017) [7]
Stroke
50/2668
45/2668
0.75
0 (0.506)
Ronning et al. (1999) [8]
Stroke
36/292
27/258
0.54
0 (0.506)
Singhal et al. (2005) [9]
Stroke
0/9
1/7
NS
0 (0.438)
NCT00414726
Stroke
14/43
4/42
0.08
2 (0.072)
Shi et al. (2017) [10]
Stroke
0/9
0/9
NS
0 (1)
NCT02378454 (2015)
Sepsis
3/25
2/25
NS
0 (1)
Butler et al. (1987) [11]
Limb ischemia
1/17
0/22
NS
0 (0.436)
Schietroma et al. (2016) [12]
Perforated peptic ulcer
2/119
4/120
0.42
0 (0648)
NCT02687217
Acute appendicitis
0/30
0/30
NS
0 (1)
Girardis et al. (2016) [5]
Critical illness
80/243
58/235
0.01
0 (0.055)
Panwar et al. (2016) [13]
Critical illness
12/51
13/53
0.44
0 (1)
Hofmann et al. (2017) [14]
Myocardial infarction
53/3311
44/3318
0.08
0 (0.359)
Khoshnood et al. (2015) [15]
Myocardial infarction
3/85
3/75
NS
0 (1)
Kuisma et al. (2006) [16]
Cardiac arrest
4/14
4/14
NS
0 (1)
Rawles et al. (1976) [17]
Myocardial infarction
9/105
3/95
NS
0 (0.140)
Stub et al. (2012) [18]
Myocardial infarction
5/132
11/132
NS
0 (0.204)
Ukholkina et al. (2005) [19]
Myocardial infarction
1/58
0/79
NS
0 (0.428)
Young et al. (2014) [20]
Cardiac arrest
5/9
4/8
NS
0 (1)
NS not significant
Literature
1.
go back to reference O’Driscoll BR, Howard LS, Earis J, et al. British Thoracic Society guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(suppl 1):ii1–90.CrossRef O’Driscoll BR, Howard LS, Earis J, et al. British Thoracic Society guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(suppl 1):ii1–90.CrossRef
2.
go back to reference Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acuyely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systemaic review and meta-analysis. Lancet. 2018;391:1693–705.CrossRef Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acuyely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systemaic review and meta-analysis. Lancet. 2018;391:1693–705.CrossRef
3.
go back to reference Walsh M, Srinathan SK, McAuley DF, et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epidemiol. 2014;67:622–8.CrossRef Walsh M, Srinathan SK, McAuley DF, et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epidemiol. 2014;67:622–8.CrossRef
4.
go back to reference Ridgeon EE, Young PJ, Bellomo R, et al. The fragility index in multicenter randomized controlled critical care trials. Crit Care Med. 2016;44:1278–84.CrossRef Ridgeon EE, Young PJ, Bellomo R, et al. The fragility index in multicenter randomized controlled critical care trials. Crit Care Med. 2016;44:1278–84.CrossRef
5.
go back to reference Girardis M, Busani S, Damiani E, et al. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA. 2016;316:1583–9.CrossRef Girardis M, Busani S, Damiani E, et al. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA. 2016;316:1583–9.CrossRef
6.
go back to reference Ali K, Warusevitane A, Lally F, et al. The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke—effect on key outcomes at six months. PLoS One. 2014;8:e59274.CrossRef Ali K, Warusevitane A, Lally F, et al. The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke—effect on key outcomes at six months. PLoS One. 2014;8:e59274.CrossRef
7.
go back to reference Roffe C, Nevatte T, Sim J, et al. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the stroke oxygen study randomized clinical trial. JAMA. 2017;318:1125–35.CrossRef Roffe C, Nevatte T, Sim J, et al. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the stroke oxygen study randomized clinical trial. JAMA. 2017;318:1125–35.CrossRef
8.
go back to reference Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999;30:2033–7.CrossRef Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999;30:2033–7.CrossRef
9.
go back to reference Singhal AB, Benner T, Roccatagliata L, et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36:797–802.CrossRef Singhal AB, Benner T, Roccatagliata L, et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36:797–802.CrossRef
10.
go back to reference Shi S, Qi Z, Ma Q, et al. Normobaric hyperoxia reduces blood occludin fragments in rats and patients with acute ischemic stroke. Stroke. 2017;48:2848–54.CrossRef Shi S, Qi Z, Ma Q, et al. Normobaric hyperoxia reduces blood occludin fragments in rats and patients with acute ischemic stroke. Stroke. 2017;48:2848–54.CrossRef
11.
go back to reference Butler CM, Ham RO, Lafferty K, Cotton LT, Roberts VC. The effect of adjuvant oxygen therapy on transcutaneous pO2 and healing in the below-knee amputee. Prosthet Orthot Int. 1987;11:10–16. Butler CM, Ham RO, Lafferty K, Cotton LT, Roberts VC. The effect of adjuvant oxygen therapy on transcutaneous pO2 and healing in the below-knee amputee. Prosthet Orthot Int. 1987;11:10–16.
12.
go back to reference Schietroma M, Cecilia EM, De Santis G, Carlei F, Pessia B, Amicucci G. Supplemental peri-operative oxygen and incision site infection after surgery for perforated peptic ulcer: a randomized, double-blind monocentric trial. Surg Infect. 2016;17:106–13.CrossRef Schietroma M, Cecilia EM, De Santis G, Carlei F, Pessia B, Amicucci G. Supplemental peri-operative oxygen and incision site infection after surgery for perforated peptic ulcer: a randomized, double-blind monocentric trial. Surg Infect. 2016;17:106–13.CrossRef
13.
go back to reference Panwar R, Hardie M, Bellomo R, et al. Conservative versus liberal oxygenation targets for mechanically ventilated patients. A pilot multicenter randomized controlled trial. Am J Respir Crit Care Med. 2016;193:43–51.CrossRef Panwar R, Hardie M, Bellomo R, et al. Conservative versus liberal oxygenation targets for mechanically ventilated patients. A pilot multicenter randomized controlled trial. Am J Respir Crit Care Med. 2016;193:43–51.CrossRef
14.
go back to reference Hofmann R, James SK, Jernberg T, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377:1240–9.CrossRef Hofmann R, James SK, Jernberg T, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377:1240–9.CrossRef
15.
go back to reference Khoshnood A, Carlsson M, Akbarzadeh M, et al. The effects of oxygen therapy on myocardial salvage in ST elevation myocardial infarction treated with acute percutaneous coronary intervention: the Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER) study. Cardiology. 2015;132:16–21.CrossRef Khoshnood A, Carlsson M, Akbarzadeh M, et al. The effects of oxygen therapy on myocardial salvage in ST elevation myocardial infarction treated with acute percutaneous coronary intervention: the Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER) study. Cardiology. 2015;132:16–21.CrossRef
16.
go back to reference Kuisma M, Boyd J, Voipio V, Alaspaa A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation. 2006;69:199–20. Kuisma M, Boyd J, Voipio V, Alaspaa A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation. 2006;69:199–20.
17.
go back to reference Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. BMJ. 1976;1:1121–23.CrossRef Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. BMJ. 1976;1:1121–23.CrossRef
18.
go back to reference Stub D, Smith K, Bernard S, et al. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study). Am Heart J. 2012;163:339–45.e1.CrossRef Stub D, Smith K, Bernard S, et al. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study). Am Heart J. 2012;163:339–45.e1.CrossRef
19.
go back to reference Ukholkina GB, Kostianov II, Kuchkina NV, Grendo EP, Gofman IB. Oxygen therapy in combination with endovascular reperfusion during the first hours of acute myocardial infarction: clinical and laboratory findings. Int J Interv Cardioangiol. 2005;9:45–51. Ukholkina GB, Kostianov II, Kuchkina NV, Grendo EP, Gofman IB. Oxygen therapy in combination with endovascular reperfusion during the first hours of acute myocardial infarction: clinical and laboratory findings. Int J Interv Cardioangiol. 2005;9:45–51.
20.
go back to reference Young P, Bailey M, Bellomo R, et al. HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): a randomised controlled feasibility trial. Resuscitation. 2014;85:1686–91.CrossRef Young P, Bailey M, Bellomo R, et al. HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): a randomised controlled feasibility trial. Resuscitation. 2014;85:1686–91.CrossRef
Metadata
Title
Liberal versus conservative oxygen therapy in critically ill patients: using the fragility index to determine robust results
Authors
Maria Vargas
Giuseppe Servillo
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2019
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-018-2165-z

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue